BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 14743395)

  • 1. Colon cancer specific nuclear matrix protein alterations in human colonic adenomatous polyps.
    Brünagel G; Schoen RE; Getzenberg RH
    J Cell Biochem; 2004 Feb; 91(2):365-74. PubMed ID: 14743395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of nuclear matrix protein alterations associated with human colon cancer.
    Brünagel G; Vietmeier BN; Bauer AJ; Schoen RE; Getzenberg RH
    Cancer Res; 2002 Apr; 62(8):2437-42. PubMed ID: 11956108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of calreticulin as a nuclear matrix protein associated with human colon cancer.
    Brünagel G; Shah U; Schoen RE; Getzenberg RH
    J Cell Biochem; 2003 May; 89(2):238-43. PubMed ID: 12704787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.
    Ho SB; Ewing SL; Montgomery CK; Kim YS
    Oncol Res; 1996; 8(2):53-61. PubMed ID: 8859775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional electrophoretic analysis of nuclear matrix proteins in human colon adenocarcinoma.
    Toumpanaki A; Baltatzis GE; Gaitanarou E; Seretis E; Toumpanakis C; Aroni K; Kittas C; Voloudakis-Baltatzis IE
    Ultrastruct Pathol; 2009; 33(2):83-91. PubMed ID: 19274585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer.
    Balasubramani M; Day BW; Schoen RE; Getzenberg RH
    Cancer Res; 2006 Jan; 66(2):763-9. PubMed ID: 16424007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of morphologic characteristics in rectosigmoid adenomatous polyps for the probability of synchronous polyps or cancer in the proximal colon.
    Erdem L; Akbayir N; Yildirim S; Köksal HM; Yenice N; Gültekin OS; Sakiz D; Peker O
    Turk J Gastroenterol; 2005 Dec; 16(4):207-11. PubMed ID: 16547849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of nuclear matrix protein alterations associated with renal cell carcinoma.
    Konety BR; Nangia AK; Nguyen TS; Veitmeier BN; Dhir R; Acierno JS; Becich MJ; Hrebinko RL; Getzenberg RH
    J Urol; 1998 Apr; 159(4):1359-63. PubMed ID: 9507884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated alterations of blood group antigen expression in human colorectal polyps.
    Itzkowitz SH; Yuan M; Ferrell LD; Palekar A; Kim YS
    Cancer Res; 1986 Nov; 46(11):5976-84. PubMed ID: 2428489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator profiles in neoplastic tissues of the human colon.
    de Bruin PA; Griffioen G; Verspaget HW; Verheijen JH; Dooijewaard G; van den Ingh HF; Lamers CB
    Cancer Res; 1988 Aug; 48(16):4520-4. PubMed ID: 3260815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and colon mucosa micronutrient antioxidants: differences between adenomatous polyp patients and controls.
    Nair S; Norkus EP; Hertan H; Pitchumoni CS
    Am J Gastroenterol; 2001 Dec; 96(12):3400-5. PubMed ID: 11774956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal adenomatous polyps.
    Itzkowitz SH
    Semin Gastrointest Dis; 1996 Apr; 7(2):105-16. PubMed ID: 8705258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear matrix protein alterations associated with colon cancer metastasis to the liver.
    Brünagel G; Schoen RE; Bauer AJ; Vietmeier BN; Getzenberg RH
    Clin Cancer Res; 2002 Oct; 8(10):3039-45. PubMed ID: 12374670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
    Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer.
    Walgenbach-Brunagel G; Burger B; Leman ES; Walgenbach KJ; Tolba R; Heukamp L; Hirner A; Getzenberg RH
    J Cell Biochem; 2008 May; 104(1):286-94. PubMed ID: 18044711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model for human colon carcinoma evolution based on the differential response of cultured preneoplastic, premalignant, and malignant cells to 12-O-tetradecanoylphorbol-13-acetate.
    Friedman E; Urmacher C; Winawer S
    Cancer Res; 1984 Apr; 44(4):1568-78. PubMed ID: 6423277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon.
    Yoshida I; Suzuki A; Vallée M; Matano Y; Masunaga T; Zenda T; Shinozaki K; Okada T
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1225-31. PubMed ID: 16979948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of decorin expression in polyps and carcinomas of the colon.
    Augoff K; Rabczynski J; Tabola R; Czapla L; Ratajczak K; Grabowski K
    Med Sci Monit; 2008 Oct; 14(10):CR530-5. PubMed ID: 18830193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder cancer-associated nuclear matrix proteins.
    Getzenberg RH; Konety BR; Oeler TA; Quigley MM; Hakam A; Becich MJ; Bahnson RR
    Cancer Res; 1996 Apr; 56(7):1690-4. PubMed ID: 8603421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.